Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain

Diabetes Care

Volumn 33, Issue 2, 2010, Pages 221-226

  Hameed, Shihab ^a,b   Morton, John R ^a,b   Jaffé, Adam ^a,b   Field, Penny I ^a   Belessis, Yvonne ^a,b   Yoong, Terence ^a   Katz, Tamarah ^a   Verge, Charles F ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LUNG FUNCTION; MALE; MONITORING; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WEIGHT CHANGE; WEIGHT GAIN;

ADOLESCENT; BLOOD GLUCOSE; BODY WEIGHT; CHILD; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; VITAL CAPACITY;

EID: 75149196364     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1492     Document Type: Article

References (28)

1. Dobson L, Sheldon CD, Hattersley AT. Understanding cystic-fibrosis- related diabetes: best thought of as insulin deficiency? J R Soc Med 2004;97(Suppl. 44): 26-35
2. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151:684-687
3. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ, Hodson ME, Anker SD, Henein MY. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001; 56:746-750
4. Bellis G, Cazes MH, Parant A, Gaimard M, Travers C, Le Roux E, Ravilly S, Rault G. Cystic fibrosis mortality trends in France. J Cyst Fibros 2007;6:179-186
5. Rodman HM, Doershuk CF, Roland JM. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986;65:389-397
6. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW 3rd, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Zipf WB. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999;45:61-73
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
8. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971;2:125-128
9. van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 2008;7:515-519
10. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA, the Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fi-brosis. J Pediatr 2007;151:134-139
11. Lai HJ, Shoff SM, Farrell PM, the Wisconsin Cystic Fibrosis Neonatal Screening Group. Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis. Pediatrics 2009;123:714-722
12. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr 2005;147:S11-S14
13. Courtney JM, Bradley J, Mccaughan J, O'Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007;42:525-532
14. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
15. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734
16. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293
17. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fi-brosis. J Pediatr 1997;131:809-814
18. O'Riordan SM, Robinson PD, Donaghue KC, Moran A, the ISPAD Clinical Practice Consensus. Management of cystic fibrosisrelated diabetes. Pediatr Diabetes 2008;9: 338-344
19. Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001;281:E1022-E1028
20. Mohan K, Miller H, Dyce P, Grainger R, Hughes R, Vora J, Ledson M, Walshaw M. Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med 2009;26:582-588
21. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995;311:655-659
22. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4:7-26
23. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis related diabetes: current trends in prevalence, incidence and mortality. Diabetes Care 2009;32:1626-1631
24. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004;21:691-696
25. Palerm C. Physiologic insulin delivery with insulin feedback: a control systems perspective. In Proceedings of the 7th IFAC Symposium on Modelling and Control in Biomedical Systems, Aalborg, Denmark, 2009. Laxenburg, Austria, International Federation of Autonomic Control, p. 31
26. Lippe BM, Sperling MA, Dooley RR. Pancreatic α and β cell functions in cystic fibrosis. J Pediatr 1977;90:751-755
27. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, the Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial. Diabetes Care 2009;32: 1783-1788
28. Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005;147:396-398